Auxilium announces XIAFLEX now approved for concurrent treatment of two affected joints
Auxilium announced the FDA has approved a supplemental Biologics Application for XIAFLEX® (collagenase clostridium histolyticum or CCH) for treatment of up to two Dupuytren's contracture (DC) joints in the same hand during a single treatment visit. October 20, 2014